New insights into a potential target for autoimmune disease

With insights into a molecular pathway that regulates the activity of Tregs, a type of T cell involved in immunosuppression, research by the University of Pennsylvania’s George Hajishengallis and colleagues opens up possibly new avenues for treating inflammatory and autoimmune diseases.